Stericycle - SRCL Stock Forecast, Price & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stericycle in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" SRCL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SRCL, but not buy additional shares or sell existing shares.
View SRCL analyst ratings or view top-rated stocks.

4 Wall Street research analysts have issued 1 year target prices for Stericycle's stock. Their SRCL share price forecasts range from $46.00 to $67.00. On average, they expect the company's share price to reach $58.67 in the next year. This suggests a possible upside of 31.8% from the stock's current price.
View analysts price targets for SRCL or view top-rated stocks among Wall Street analysts.

Stericycle's stock was trading at $59.64 at the beginning of the year. Since then, SRCL stock has decreased by 25.4% and is now trading at $44.51.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our SRCL earnings forecast.

Stericycle, Inc. (NASDAQ:SRCL) posted its quarterly earnings data on Friday, August, 5th. The business services provider reported $0.48 EPS for the quarter, beating the consensus estimate of $0.43 by $0.05. The business services provider earned $679.80 million during the quarter, compared to analysts' expectations of $678.27 million. Stericycle had a positive trailing twelve-month return on equity of 6.22% and a negative net margin of 3.28%. The company's revenue for the quarter was up 1.1% compared to the same quarter last year. During the same period last year, the business posted $0.67 EPS.

Stericycle updated its FY 2022 earnings guidance on Friday, September, 2nd. The company provided earnings per share guidance of $2.00-$2.15 for the period, compared to the consensus earnings per share estimate of $2.07. The company issued revenue guidance of -.

132 employees have rated Stericycle Chief Executive Officer Cindy Miller on Glassdoor.com. Cindy Miller has an approval rating of 74% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Stericycle investors own include Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Starbucks (SBUX), Walt Disney (DIS), QUALCOMM (QCOM), Johnson & Johnson (JNJ), AbbVie (ABBV), Fastenal (FAST) and Gilead Sciences (GILD).

Stericycle trades on the NASDAQ under the ticker symbol "SRCL."

Shares of SRCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SRCL stock can currently be purchased for approximately $44.51.

Stericycle (NASDAQ:SRCL) has a market capitalization of $4.10 billion and generates $2.65 billion in revenue each year. The business services provider earns $-27,800,000.00 in net income (profit) each year or ($0.95) on an earnings per share basis.

The company employs 15,000 workers across the globe.

Stericycle's mailing address is 2355 WAUKEGAN ROAD, BANNOCKBURN IL, 60015. The official website for the company is www.stericycle.com. The business services provider can be reached via phone at (847) 367-5910, via email at investor@stericycle.com, or via fax at 847-367-9493.